CAPR vs RF
Capricor Therapeutics Inc (CAPR) versus RF (RF) — a side-by-side from cached financials, not a winner call.
Capricor Therapeutics Inc (CAPR) is a biotechnology company listed on NASDAQ.
RF (RF) common stock.
Latest reported CAPR revenue for 2025-12-31 was $0. Net income was -$105.0M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. CAPR currently screens at market cap $1.62B.
RF does not have a complete income-statement cache yet.
CAPR currently screens at market cap $1.62B. RF currently screens at market cap $0.
Not investment advice. Open the CAPR and RF stock pages for the full models.
Not investment advice.